Senior Scientist
United States Pharmacopeia, Maryland, United States
Ben Clarke comes from the United States Pharmacopeia’s Global Biologics group, where he develops physical and documentary reference standards. The set of Biologics standards that he supports include standards for cell and gene therapy and for monoclonal antibodies. Before joining USP, Ben developed analytical bioassays for RSV and and self-amplifying mRNA vaccines at GSK Vaccines. Before GSK Vaccines, he developed mouse models using the newly emerging CRISPR/Cas9 genome editing system to study sphingolipid biology at the National Institutes of Health. He received his Ph.D. from Cornell University for his work on mammalian membrane biology and lipid remodeling. He received his B.S. from Pennsylvania State University’s department of Biochemistry, Molecular, and Cell Biology.
Disclosure information not submitted.
Tuesday, April 25, 2023
10:00 AM – 10:30 AM ET